190. Baseline characteristics of patients from a phase 3 program to assess abobotulinumtoxinA (Dysport) in the treatment of spasticity and functional impairments in children with dynamic equinus foot deformity due to cerebral palsy
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.